Thus, this may suggest that miR-29c utilizes a neuroprotective effect via the BDNF/TrkB/Erk signaling pathway and it can be a possible therapeutic approach for the management of AD [44]. This evidence concerns the gene NTRK2 and Alzheimer disease.